LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 38

Search options

  1. Article: "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?

    Medina-Kauwe, L K

    Advanced drug delivery reviews

    2007  Volume 59, Issue 8, Page(s) 798–809

    Abstract: Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as ... ...

    Abstract Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as alternatives to clathrin-mediated endocytosis, that are known to facilitate entry of pathogens and potential delivery agents. Recent characterization of the trafficking mechanisms of prion proteins and certain bacteria may present new paradigms for strategizing improvements in therapeutic spread and retention of therapy. This review will provide an overview of such endocytic pathways, and discuss current and future possibilities in using these routes as a means to improve therapeutic delivery.
    MeSH term(s) Animals ; Bacterial Toxins/metabolism ; Biological Transport ; Caveolae/metabolism ; Caveolae/microbiology ; Clathrin/chemistry ; Clathrin/metabolism ; Clathrin-Coated Vesicles/metabolism ; Coated Pits, Cell-Membrane/chemistry ; Coated Pits, Cell-Membrane/metabolism ; Drug Delivery Systems ; Endocytosis/physiology ; Endoplasmic Reticulum/metabolism ; Endosomes/chemistry ; Endosomes/metabolism ; Golgi Apparatus/chemistry ; Golgi Apparatus/metabolism ; Intracellular Signaling Peptides and Proteins ; Prions/chemistry ; Prions/metabolism ; Toxins, Biological/chemistry ; Toxins, Biological/metabolism ; Vesicular Transport Proteins/metabolism ; trans-Golgi Network/chemistry ; trans-Golgi Network/metabolism
    Chemical Substances Bacterial Toxins ; Clathrin ; Intracellular Signaling Peptides and Proteins ; Prions ; Toxins, Biological ; Vesicular Transport Proteins
    Keywords covid19
    Language English
    Publishing date 2007-07-05
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 639113-8
    ISSN 1872-8294 ; 0169-409X
    ISSN (online) 1872-8294
    ISSN 0169-409X
    DOI 10.1016/j.addr.2007.06.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Introduction to the special issue: traveling the intracellular highway to gene therapy.

    Medina-Kauwe, L K

    Gene therapy

    2005  Volume 12, Issue 11, Page(s) 863–864

    MeSH term(s) Gene Transfer Techniques ; Genetic Therapy/methods ; Genetic Vectors/pharmacokinetics ; Humans ; Signal Transduction
    Language English
    Publishing date 2005-06
    Publishing country England
    Document type Editorial
    ZDB-ID 1191036-7
    ISSN 1476-5462 ; 0969-7128
    ISSN (online) 1476-5462
    ISSN 0969-7128
    DOI 10.1038/sj.gt.3302551
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Analysis of targeted viral protein nanoparticles delivered to HER2+ tumors.

    Hwang, Jae Youn / Farkas, Daniel L / Medina-Kauwe, Lali K

    Journal of visualized experiments : JoVE

    2013  , Issue 76

    Abstract: The HER2+ tumor-targeted nanoparticle, HerDox, exhibits tumor-preferential accumulation and tumor-growth ablation in an animal model of HER2+ cancer. HerDox is formed by non-covalent self-assembly of a tumor targeted cell penetration protein with the ... ...

    Abstract The HER2+ tumor-targeted nanoparticle, HerDox, exhibits tumor-preferential accumulation and tumor-growth ablation in an animal model of HER2+ cancer. HerDox is formed by non-covalent self-assembly of a tumor targeted cell penetration protein with the chemotherapy agent, doxorubicin, via a small nucleic acid linker. A combination of electrophilic, intercalation, and oligomerization interactions facilitate self-assembly into round 10-20 nm particles. HerDox exhibits stability in blood as well as in extended storage at different temperatures. Systemic delivery of HerDox in tumor-bearing mice results in tumor-cell death with no detectable adverse effects to non-tumor tissue, including the heart and liver (which undergo marked damage by untargeted doxorubicin). HER2 elevation facilitates targeting to cells expressing the human epidermal growth factor receptor, hence tumors displaying elevated HER2 levels exhibit greater accumulation of HerDox compared to cells expressing lower levels, both in vitro and in vivo. Fluorescence intensity imaging combined with in situ confocal and spectral analysis has allowed us to verify in vivo tumor targeting and tumor cell penetration of HerDox after systemic delivery. Here we detail our methods for assessing tumor targeting via multimode imaging after systemic delivery.
    MeSH term(s) Animals ; Antibiotics, Antineoplastic/administration & dosage ; Antibiotics, Antineoplastic/chemistry ; Antibiotics, Antineoplastic/pharmacokinetics ; Breast Neoplasms/drug therapy ; Breast Neoplasms/enzymology ; Breast Neoplasms/metabolism ; Cell Line, Tumor ; Doxorubicin/administration & dosage ; Doxorubicin/chemistry ; Doxorubicin/pharmacokinetics ; Drug Stability ; Female ; Humans ; Mice ; Mice, Nude ; Microscopy, Fluorescence/methods ; Nanoparticles/administration & dosage ; Nanoparticles/chemistry ; Receptor, ErbB-2/metabolism ; Xenograft Model Antitumor Assays
    Chemical Substances Antibiotics, Antineoplastic ; Doxorubicin (80168379AG) ; Receptor, ErbB-2 (EC 2.7.10.1)
    Language English
    Publishing date 2013-06-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Video-Audio Media
    ZDB-ID 2259946-0
    ISSN 1940-087X ; 1940-087X
    ISSN (online) 1940-087X
    ISSN 1940-087X
    DOI 10.3791/50396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Large Field of View Scanning Fluorescence Lifetime Imaging System for Multimode Optical Imaging of Small Animals.

    Hwang, Jae Youn / Agadjanian, Hasmik / Medina-Kauwe, Lali K / Gross, Zeev / Gray, Harry B / Sorasaenee, Karn / Farkas, Daniel L

    Proceedings of SPIE--the International Society for Optical Engineering

    2017  Volume 6859

    Abstract: We describe a scanning fluorescence lifetime imaging (SFLIM) system that provides a large field of view (LFOV), using a femtosecond (fs) pulsed laser, for multi-mode optical imaging of small animals. Fluorescence lifetime imaging (FLIM) can be a useful ... ...

    Abstract We describe a scanning fluorescence lifetime imaging (SFLIM) system that provides a large field of view (LFOV), using a femtosecond (fs) pulsed laser, for multi-mode optical imaging of small animals. Fluorescence lifetime imaging (FLIM) can be a useful optical method to distinguish between fluorophores inside small animals. However, difficulty arises when LFOV is required in FLIM using a fs pulsed laser for the excitation of the fluorophores at low wavelengths (<500nm), primarily because the field of view of the pulsed blue excitation light generated from the second harmonic of the fs pulsed light is limited to about a centimeter in diameter due to the severe scattering and absorption of the light inside tissues. Here, we choose a scanning method in order to acquire a FLIM image with LFOV as one alternative. In the SFLIM system, we used a conventional cooled CCD camera coupled to an ultra-fast time-gated intensifier, a tunable femtosecond laser for the excitation of fluorophores, and an x-y moving stage for scanning. Images acquired through scanning were combined into a single image and then this reconstructed image was compared with images obtained by spectral imaging. The resulting SFLIM system is promising as an alternative method for the FLIM imaging of small animals, containing fluorophores exited by blue light, for LFOV applications such as whole animal imaging.
    Language English
    Publishing date 2017-12-18
    Publishing country United States
    Document type Journal Article
    ISSN 0277-786X
    ISSN 0277-786X
    DOI 10.1117/12.769305
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo.

    Yue, Peibin / Zhu, Yinsong / Brotherton-Pleiss, Christine / Fu, Wenzhen / Verma, Nagendra / Chen, Jasmine / Nakamura, Kayo / Chen, Weiliang / Chen, Yue / Alonso-Valenteen, Felix / Mikhael, Simoun / Medina-Kauwe, Lali / Kershaw, Kathleen M / Celeridad, Maria / Pan, Songqin / Limpert, Allison S / Sheffler, Douglas J / Cosford, Nicholas D P / Shiao, Stephen L /
    Tius, Marcus A / Lopez-Tapia, Francisco / Turkson, James

    Cancer letters

    2022  Volume 534, Page(s) 215613

    Abstract: Signal transducer and activator of transcription (Stat)3 is a valid anticancer therapeutic target. We have discovered a highly potent chemotype that amplifies the Stat3-inhibitory activity of lead compounds to levels previously unseen. The azetidine- ... ...

    Abstract Signal transducer and activator of transcription (Stat)3 is a valid anticancer therapeutic target. We have discovered a highly potent chemotype that amplifies the Stat3-inhibitory activity of lead compounds to levels previously unseen. The azetidine-based compounds, including H172 (9f) and H182, irreversibly bind to Stat3 and selectively inhibit Stat3 activity (IC
    MeSH term(s) Animals ; Apoptosis ; Azetidines/pharmacology ; Cell Line, Tumor ; Humans ; Mice ; Phosphorylation ; STAT3 Transcription Factor/metabolism ; Signal Transduction ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/genetics
    Chemical Substances Azetidines ; STAT3 Transcription Factor ; STAT3 protein, human ; azetidine (37S883XDWR)
    Language English
    Publishing date 2022-03-09
    Publishing country Ireland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 195674-7
    ISSN 1872-7980 ; 0304-3835
    ISSN (online) 1872-7980
    ISSN 0304-3835
    DOI 10.1016/j.canlet.2022.215613
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Multimode Optical Imaging for Translational Chemotherapy: In Vivo Tumor Detection and Delineation by Targeted Gallium Corroles.

    Hwang, Jae Youn / Gross, Zeev / Gray, Harry B / Medina-Kauwe, Lali K / Farkas, Daniel L

    Proceedings of SPIE--the International Society for Optical Engineering

    2014  Volume 7902

    Abstract: We report the feasibility of tumor detection and ... ...

    Abstract We report the feasibility of tumor detection and delineation
    Language English
    Publishing date 2014-10-17
    Publishing country United States
    Document type Journal Article
    ISSN 0277-786X
    ISSN 0277-786X
    DOI 10.1117/12.877780
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.

    Brotherton-Pleiss, Christine / Yue, Peibin / Zhu, Yinsong / Nakamura, Kayo / Chen, Weiliang / Fu, Wenzhen / Kubota, Casie / Chen, Jasmine / Alonso-Valenteen, Felix / Mikhael, Simoun / Medina-Kauwe, Lali / Tius, Marcus A / Lopez-Tapia, Francisco / Turkson, James

    Journal of medicinal chemistry

    2020  Volume 64, Issue 1, Page(s) 695–710

    Abstract: We optimized our previously reported proline-based STAT3 inhibitors into an exciting new series of ( ...

    Abstract We optimized our previously reported proline-based STAT3 inhibitors into an exciting new series of (
    MeSH term(s) Amides/chemistry ; Apoptosis/drug effects ; Azetidines/chemistry ; Azetidines/metabolism ; Azetidines/pharmacology ; Cell Line, Tumor ; Cell Survival/drug effects ; DNA/chemistry ; DNA/metabolism ; Drug Evaluation, Preclinical ; Humans ; Inhibitory Concentration 50 ; Phosphorylation/drug effects ; Protein Binding ; STAT3 Transcription Factor/antagonists & inhibitors ; STAT3 Transcription Factor/metabolism ; Structure-Activity Relationship
    Chemical Substances Amides ; Azetidines ; STAT3 Transcription Factor ; STAT3 protein, human ; DNA (9007-49-2)
    Language English
    Publishing date 2020-12-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.0c01705
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Investigating the photosensitizer-potential of targeted gallium corrole using multimode optical imaging.

    Hwang, Jae Youn / Lubow, Jay / Chu, David / Gross, Zeev / Gray, Harry B / Farkas, Daniel L / Medina-Kauwe, Lali K

    Proceedings of SPIE--the International Society for Optical Engineering

    2014  Volume 7886

    Abstract: We recently developed a novel therapeutic particle, HerGa, for breast cancer treatment and detection. HerGa consists of a tumor-targeted cell penetration protein noncovalently assembled with a gallium-metallated corrole. The corrole is structurally ... ...

    Abstract We recently developed a novel therapeutic particle, HerGa, for breast cancer treatment and detection. HerGa consists of a tumor-targeted cell penetration protein noncovalently assembled with a gallium-metallated corrole. The corrole is structurally similar to porphyrin, emits intense fluorescence, and has proven highly effective for breast tumor treatment preclinically, without light exposure. Here, we tested HerGa as a photosensitizer for photodynamic therapy and investigated its mechanism of action using multimode optical imaging. Using confocal fluorescence imaging, we observed that HerGa disrupts the mitochondrial membrane potential
    Language English
    Publishing date 2014-11-18
    Publishing country United States
    Document type Journal Article
    ISSN 0277-786X
    ISSN 0277-786X
    DOI 10.1117/12.873337
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Ratiometric spectral imaging for fast tumor detection and chemotherapy monitoring in vivo.

    Hwang, Jae Youn / Gross, Zeev / Gray, Harry B / Medina-Kauwe, Lali K / Farkas, Daniel L

    Journal of biomedical optics

    2011  Volume 16, Issue 6, Page(s) 66007

    Abstract: We report a novel in vivo spectral imaging approach to cancer detection and chemotherapy assessment. We describe and characterize a ratiometric spectral imaging and analysis method and evaluate its performance for tumor detection and delineation by ... ...

    Abstract We report a novel in vivo spectral imaging approach to cancer detection and chemotherapy assessment. We describe and characterize a ratiometric spectral imaging and analysis method and evaluate its performance for tumor detection and delineation by quantitatively monitoring the specific accumulation of targeted gallium corrole (HerGa) into HER2-positive (HER2 +) breast tumors. HerGa temporal accumulation in nude mice bearing HER2 + breast tumors was monitored comparatively by a. this new ratiometric imaging and analysis method; b. established (reflectance and fluorescence) spectral imaging; c. more commonly used fluorescence intensity imaging. We also tested the feasibility of HerGa imaging in vivo using the ratiometric spectral imaging method for tumor detection and delineation. Our results show that the new method not only provides better quantitative information than typical spectral imaging, but also better specificity than standard fluorescence intensity imaging, thus allowing enhanced in vivo outlining of tumors and dynamic, quantitative monitoring of targeted chemotherapy agent accumulation into them.
    MeSH term(s) Algorithms ; Animals ; Contrast Media/pharmacokinetics ; Drug Monitoring/methods ; Female ; Gallium/pharmacokinetics ; Mice ; Mice, Nude ; Molecular Imaging/methods ; Neoplasms/drug therapy ; Neoplasms/enzymology ; Neoplasms/metabolism ; Neoplasms/pathology ; Receptor, ErbB-2/biosynthesis ; Spectrometry, Fluorescence ; Transplantation, Heterologous
    Chemical Substances Contrast Media ; Gallium (CH46OC8YV4) ; Erbb2 protein, mouse (EC 2.7.10.1) ; Receptor, ErbB-2 (EC 2.7.10.1)
    Language English
    Publishing date 2011-07-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1309154-2
    ISSN 1560-2281 ; 1083-3668
    ISSN (online) 1560-2281
    ISSN 1083-3668
    DOI 10.1117/1.3589299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Multimodality imaging in vivo for preclinical assessment of tumor-targeted doxorubicin nanoparticles.

    Hwang, Jae Youn / Park, Jinhyoung / Kang, Bong Jin / Lubow, David J / Chu, David / Farkas, Daniel L / Shung, K Kirk / Medina-Kauwe, Lali K

    PloS one

    2012  Volume 7, Issue 4, Page(s) e34463

    Abstract: This study presents a new multimodal imaging approach that includes high-frequency ultrasound, fluorescence intensity, confocal, and spectral imaging to improve the preclinical evaluation of new therapeutics in vivo. Here we use this approach to assess ... ...

    Abstract This study presents a new multimodal imaging approach that includes high-frequency ultrasound, fluorescence intensity, confocal, and spectral imaging to improve the preclinical evaluation of new therapeutics in vivo. Here we use this approach to assess in vivo the therapeutic efficacy of the novel chemotherapy construct, HerDox during and after treatment. HerDox is comprised of doxorubicin non-covalently assembled in a viral-like particle targeted to HER2+ tumor cells, causing tumor cell death at over 10-fold lower dose compared to the untargeted drug, while sparing the heart. Whereas our initial proof-of-principle studies on HerDox used tumor growth/shrinkage rates as a measure of therapeutic efficacy, here we show that multimodal imaging deployed during and after treatment can supplement traditional modes of tumor monitoring to further characterize the particle in tissues of treated mice. Specifically, we show here that tumor cell apoptosis elicited by HerDox can be monitored in vivo during treatment using high frequency ultrasound imaging, while in situ confocal imaging of excised tumors shows that HerDox indeed penetrated tumor tissue and can be detected at the subcellular level, including in the nucleus, via Dox fluorescence. In addition, ratiometric spectral imaging of the same tumor tissue enables quantitative discrimination of HerDox fluorescence from autofluorescence in situ. In contrast to standard approaches of preclinical assessment, this new method provides multiple/complementary information that may shorten the time required for initial evaluation of in vivo efficacy, thus potentially reducing the time and cost for translating new drug molecules into the clinic.
    MeSH term(s) Animals ; Apoptosis/drug effects ; Cell Line, Tumor ; Doxorubicin/chemistry ; Doxorubicin/metabolism ; Doxorubicin/pharmacology ; Drug Screening Assays, Antitumor ; Female ; Humans ; Mice ; Molecular Imaging/methods ; Molecular Targeted Therapy ; Nanoparticles ; Receptor, ErbB-2/metabolism ; Spectrometry, Fluorescence ; Treatment Outcome ; Ultrasonics
    Chemical Substances Doxorubicin (80168379AG) ; Receptor, ErbB-2 (EC 2.7.10.1)
    Language English
    Publishing date 2012-04-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0034463
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top